Carcinoma: all 6,718 studies
Page 25 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00103259Phase 2Results posted
- BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)CompletedNCT00101413Phase 2Results posted
- Lapatinib in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00096447Phase 2Results posted
- Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00096200Phase 2Results posted
- Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and NeckCompletedNCT00096174Phase 2Results posted
- Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00095979Phase 2Results posted
- SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00095628Phase 2Results posted
- Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland CancersCompletedNCT00095563Phase 2Results posted
- Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)CompletedNCT00094497Phase 3Results posted
- Temsirolimus in Treating Patients With Metastatic Neuroendocrine CarcinomaCompletedNCT00093782Phase 2Results posted
- SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell CarcinomaCompletedNCT00089648Phase 2Results posted
- Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00084682Phase 2Results posted
- Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and NeckCompletedNCT00084318Phase 2Results posted
- SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell CarcinomaCompletedNCT00083889Phase 3Results posted
- Doxorubicin and Bortezomib in Treating Patients With Liver CancerCompletedNCT00083226Phase 2Results posted
- A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.CompletedNCT00077974Phase 2Results posted
- Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00072566Phase 2Results posted
- Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial CancerCompletedNCT00072176Phase 2Results posted
- Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical CancerTerminatedNCT00070317Not applicableResults posted
- Vaccine Therapy in Treating Patients With Transitional Cell CarcinomasCompletedNCT00070070Phase 1Results posted
- Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the VulvaCompletedNCT00068406Phase 2Results posted
- Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell CarcinomaCompletedNCT00068393Phase 2Results posted
- Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown PrimaryCompletedNCT00066781Phase 2Results posted
- Study Evaluating Interferon And CCI-779 In Advanced Renal Cell CarcinomaCompletedNCT00065468Phase 3Results posted
- Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the CervixCompletedNCT00064077Phase 3Results posted
- Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine CorpusCompletedNCT00064025Phase 2Results posted
- Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical CancerCompletedNCT00057863Phase 2Results posted
- ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the SkinCompletedNCT00054691Phase 2Results posted
- Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation TherapyCompletedNCT00053898Phase 3Results posted
- Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell TumorsCompletedNCT00053352Phase 3Results posted
- Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal CarcinomatosisCompletedNCT00052962Phase 3Results posted
- A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular CarcinomaCompletedNCT00044512Phase 2Results posted
- BMS 247550 to Treat Kidney CancerCompletedNCT00030992Phase 2Results posted
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00011986Phase 3Results posted
- Carboplatin Combined With Paclitaxel in Treating Patients With Advanced ThymomaCompletedNCT00010257Phase 2Results posted
- Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial CancerStatus unknownNCT00006903Phase 2Results posted
- Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00006011Phase 3Results posted
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland CancerTerminatedNCT00003453Phase 2Results posted
- Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell CarcinomaTerminatedNCT00001703Phase 2Results posted
- Epidemiological, Clinicopathological, and Surgical Characteristics of Eyelid CarcinomasCompletedNCT07723365
- BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder CancerActive, not recruitingNCT07511517
- Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma LesionsActive, not recruitingNCT07470827
- Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal FailureTerminatedNCT07117409
- Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients.CompletedNCT07117071
- Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.Active, not recruitingNCT07011329
- Serum Lipid Profile and Lip Squamous Cell CarcinomaCompletedNCT07005115
- PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and SafetyCompletedNCT06991907Not applicable
- Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal MalignanciesCompletedNCT06978595
- NGS-based Germline and Somatic Genetic Test in Ovarian CarcinomaActive, not recruitingNCT06972693Phase 4
- Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular CarcinomaActive, not recruitingNCT06966986
- Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)CompletedNCT06947395
- Intraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial CarcinomaCompletedNCT06941038
- Evaluation of Swallowing Muscles Using Ultrasonography and Shear Wave Elastography in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma DiagnosisCompletedNCT06934837
- Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical ResectionActive, not recruitingNCT06934070
- SIRT or TACE Plus Lenvatinib and PD-(L)1 Inhibitor in High Burden HCCCompletedNCT06916546
- Nivolumab Plus Metformin in Metastatic Renal Cell CarcinomaTerminatedNCT06884683Phase 2
- Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort StudyCompletedNCT06883565
- Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: an MRI StudyActive, not recruitingNCT06881225
- Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in ChinaCompletedNCT06880848Phase 4
- Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung CarcinomasActive, not recruitingNCT06872541Phase 2/3
- Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell CarcinomaCompletedNCT06854107
- Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLCNo longer availableNCT06841874
- The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）Active, not recruitingNCT06828718
- Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver TransplantationCompletedNCT06799468
- Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceCompletedNCT06789224Not applicable
- Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical CarcinomaCompletedNCT06781073Phase 3
- Surgical Strategy for Head and Neck Adenoid Cystic CancerCompletedNCT06778915
- Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma PatientsCompletedNCT06778538
- Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular CarcinomaCompletedNCT06776185
- Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCCCompletedNCT06775652Phase 3
- Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the CervixActive, not recruitingNCT06771596Phase 2
- Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal CarcinomaActive, not recruitingNCT06762470
- NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCCActive, not recruitingNCT06762158Not applicable
- A Comparative Analysis of Ultrasound's Accuracy in Diagnosing HC Using Histopathology as Gold StandardActive, not recruitingNCT06748755
- Role of MRI Breast in Detection of Ductal Carcinoma in SituActive, not recruitingNCT06744140
- RT for Cervical Adenocarcinoma/adenosquamous CarcinomaActive, not recruitingNCT06741046
- Ex-vivo Hypotermic Perfusion in Patients with Hepatocellular Carcinoma to Reduce the Incidence of Tumor RecurrenceCompletedNCT06720675
- Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma OrganoidActive, not recruitingNCT06699524
- A Clinical Trial of Esophagectomy for Esophageal CarcinomaCompletedNCT06691503Phase 2
- Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal CarcinomaCompletedNCT06676293Not applicable
- Different Abbreviated MRI for Hepatocellular Carcinoma DiagnosisCompletedNCT06663904
- ML Decision Model for G-NEC Adjuvant TherapyCompletedNCT06663852
- A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell CarcinomaCompletedNCT06656039
- Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell CarcinomaWithdrawnNCT06644079Phase 2
- Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal CarcinomaActive, not recruitingNCT06642506
- HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCCActive, not recruitingNCT06632106
- A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in PakistanCompletedNCT06629857
- A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.CompletedNCT06626724
- Calculator Predicts Early Mortality Post Hepatocellular Carcinoma ResectionCompletedNCT06621485
- Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy AloneActive, not recruitingNCT06612697
- Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCCCompletedNCT06607809
- Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell CarcinomaCompletedNCT06606301
- Health Outcomes of Nasopharyngeal Carcinoma Patients Three Years After Treatment by the AI-assisted Home Enteral Nutrition ManagementCompletedNCT06603909Not applicable
- Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma of Patients With Lung CancerCompletedNCT06595498Not applicable
- Clinical and Surgical Outcomes of Thyroid Carcinoma in Children and AdolescentsCompletedNCT06592118
- "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular CarcinomaActive, not recruitingNCT06590844Phase 4
- A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort StudyCompletedNCT06559046
- Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC PatientsCompletedNCT06550739
- Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular CarcinomaActive, not recruitingNCT06524466Phase 2
- A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal CancerWithdrawnNCT06513884Phase 2/3